Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Lefebvre

Showing results (111-120 of 150) with videos related to

Pageof 15
Sort By:
Computational and Structural Biotechnology Journal|November 15, 2021
Lipidomics and metabolomics signatures of SARS-CoV-2 mediators/receptors in peripheral leukocytes, jejunum and colonJordi Mayneris-Perxachs, José Maria Moreno-Navarrete, Marta Ballanti, et al.
ACS Chemical Biology|January 7, 2017
Inactivation of the Nuclear Orphan Receptor COUP-TFII by Small ChemicalsRémy Le Guével, Frédérik Oger, Celia P Martinez-Jimenez, et al.
Journal of Hepatology|July 8, 2018
The nuclear bile acid receptor FXR is a PKA- and FOXA2-sensitive activator of fasting hepatic gluconeogenesisMaheul Ploton, Claire Mazuy, Céline Gheeraert, et al.
The Journal of Experimental Medicine|April 13, 2005
Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gammaChristel Rousseaux, Bruno Lefebvre, Laurent Dubuquoy, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 25, 2004
Regulation of human apoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor alpha modulationHélène Duez, Bruno Lefebvre, Philippe Poulain, et al.
Biological Psychiatry|December 3, 2014
Sexual orientation modulates endocrine stress reactivityRobert-Paul Juster, Mark L Hatzenbuehler, Adrianna Mendrek, et al.
Journal of Hepatology|February 24, 2015
PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitisSven Francque, An Verrijken, Sandrine Caron, et al.
Molecular Metabolism|September 23, 2016
Demonstration of a day-night rhythm in human skeletal muscle oxidative capacityDirk van Moorsel, Jan Hansen, Bas Havekes, et al.
The Journal of Clinical Endocrinology and Metabolism|September 23, 2017
Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese SubjectsVanessa Legry, Sven Francque, Joel T Haas, et al.
Atherosclerosis|September 28, 2018
Circulating PCSK9 levels are not associated with the severity of hepatic steatosis and NASH in a high-risk populationMatthieu Wargny, Pierre-Henri Ducluzeau, Jean-Michel Petit, et al.
Pageof 15

Showing results (111-120 of 150) with videos related to

Sort By:
Pageof 15
Computational and Structural Biotechnology Journal|November 15, 2021
Lipidomics and metabolomics signatures of SARS-CoV-2 mediators/receptors in peripheral leukocytes, jejunum and colonJordi Mayneris-Perxachs, José Maria Moreno-Navarrete, Marta Ballanti, et al.
ACS Chemical Biology|January 7, 2017
Inactivation of the Nuclear Orphan Receptor COUP-TFII by Small ChemicalsRémy Le Guével, Frédérik Oger, Celia P Martinez-Jimenez, et al.
Journal of Hepatology|July 8, 2018
The nuclear bile acid receptor FXR is a PKA- and FOXA2-sensitive activator of fasting hepatic gluconeogenesisMaheul Ploton, Claire Mazuy, Céline Gheeraert, et al.
The Journal of Experimental Medicine|April 13, 2005
Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gammaChristel Rousseaux, Bruno Lefebvre, Laurent Dubuquoy, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 25, 2004
Regulation of human apoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor alpha modulationHélène Duez, Bruno Lefebvre, Philippe Poulain, et al.
Biological Psychiatry|December 3, 2014
Sexual orientation modulates endocrine stress reactivityRobert-Paul Juster, Mark L Hatzenbuehler, Adrianna Mendrek, et al.
Journal of Hepatology|February 24, 2015
PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitisSven Francque, An Verrijken, Sandrine Caron, et al.
Molecular Metabolism|September 23, 2016
Demonstration of a day-night rhythm in human skeletal muscle oxidative capacityDirk van Moorsel, Jan Hansen, Bas Havekes, et al.
The Journal of Clinical Endocrinology and Metabolism|September 23, 2017
Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese SubjectsVanessa Legry, Sven Francque, Joel T Haas, et al.
Atherosclerosis|September 28, 2018
Circulating PCSK9 levels are not associated with the severity of hepatic steatosis and NASH in a high-risk populationMatthieu Wargny, Pierre-Henri Ducluzeau, Jean-Michel Petit, et al.
Pageof 15